Multicenter evaluation of efficacy and safety of low-dose versus high-dose valganciclovir for prevention of cytomegalovirus disease in donor and recipient positive (D+/R+) renal transplant recipients. [electronic resource]
Producer: 20170804Description: 904-912 p. digitalISSN:- 1399-3062
- Adult
- Allografts -- virology
- Antibiotic Prophylaxis -- methods
- Antiviral Agents -- administration & dosage
- Cytomegalovirus -- isolation & purification
- Cytomegalovirus Infections -- blood
- Female
- Follow-Up Studies
- Ganciclovir -- administration & dosage
- Graft Rejection -- epidemiology
- Humans
- Immunosuppression Therapy -- methods
- Incidence
- Kidney Transplantation -- adverse effects
- Male
- Middle Aged
- Opportunistic Infections -- epidemiology
- Practice Guidelines as Topic
- Retrospective Studies
- Serologic Tests
- Transplant Recipients
- Treatment Outcome
- Valganciclovir
No physical items for this record
Publication Type: Comparative Study; Journal Article; Multicenter Study
There are no comments on this title.
Log in to your account to post a comment.